ARIXA PHARMACEUTICALS
Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections, an urgent need. Their lead program is an oral prodrug of Avibactam, a broad spectrum beta-lactamase inhibitor recently approved by FDA. They have addressed and solved the medicinal chemistry issues which complicate the prodrugging of this class of compounds, and expect to receive broad composition of matter patent protection.
ARIXA PHARMACEUTICALS
Industry:
Emergency Medicine Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.arixapharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13 M USD
Technology used in webpage:
SPF Oracle Cloud
Similar Organizations
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.arixapharma.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
More informations about "Arixa Pharmaceuticals"
Arixa Pharmaceuticals - Crunchbase Company Profile
Contact Email [email protected] Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections, an urgent need. Their lead …See details»
Arixa Pharmaceuticals - Craft
Arixa Pharmaceuticals is a company that develops oral antibiotics for resistant gram-negative infections. It applies prodrug chemistry to existing intravenous-only antimicrobial agents to …See details»
Arixa Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 16, 2023 Explore Arixa Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 1 literature, Disease Domain ...See details»
Arixa Pharmaceuticals Inc - Company Profile and News
Company profile page for Arixa Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Arixa Pharmaceuticals - PitchBook
Arixa Pharmaceuticals General Information Description. Producer of oral antibiotics intended for resistant Gram-negative infections. The company created a series of safe oral prodrugs of avibactam, a β-lactamase inhibitor approved …See details»
Arixa Pharmaceuticals - Company Profile - Tracxn
Oct 13, 2024 Arixa Pharmaceuticals - Developer of prodrug for resistant gram-negative infections. Raised a total funding of $8M over 1 round. Founded by Eric Gordon and John …See details»
Arixa Pharmaceuticals - Overview, News & Similar companies
Oct 22, 2020 www.arixapharma.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. Could Arixa Pharmaceuticals’ Lead Product Pave the …See details»
Arixa Pharmaceuticals CEO and Key Executive Team | Craft.co
Arixa Pharmaceuticals's Co-Founder & Chief Scientific Officer is Eric Gordon. Other executives include John Freund, Co-Founder & Chief Executive Officer; Joaquim Trias, Co-Founder & …See details»
Pfizer will buy antibiotic maker Arixa - Chemical & Engineering News
Oct 31, 2020 Pfizer has agreed to buy Arixa Pharmaceuticals, a California-based company developing oral antibiotics for drug-resistant infections. Pfizer will advance Arixa’s lead …See details»
Arixa Pharmaceuticals Announces Acquisition by …
Oct 22, 2020 Contacts. Ryo Imai / Robert Flamm, Ph.D. Burns McClellan, on behalf of Arixa Pharmaceuticals [email protected] / [email protected] (212) 300-8315 / (212) 300-8364See details»
Arixa Pharma to be acquired by Pfizer’s Hospital Business
Oct 23, 2020 Pfizer to develop ARX-1796 which, if approved, has potential to be the first novel oral beta-lactamase inhibitor + antibiotic combination in more than 35 yearsSee details»
Pfizer Expands Antibacterial Portfolio by Acquiring Antibiotic Drug …
Oct 28, 2020 By Ruchi Jhonsa, Ph.D. O n 22 nd October, Pfizer’s Hospital Business announced the acquisition of Arixa Pharmaceuticals, a company dedicated to developing next-generation …See details»
Arixa Pharmaceuticals Announces Acquisition by Pfizer’s
Oct 22, 2020 PALO ALTO, Calif.--(BUSINESS WIRE)-- Arixa Pharmaceuticalsâ„¢, Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram …See details»
Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital ...
Oct 22, 2020 “We are proud to have created and developed an important new drug candidate in a highly capital efficient manner, and believe Pfizer is the perfect company to take ARX-1796 …See details»
Pfizer Hospital Business to acquire Arixa Pharma - Medical Dialogues
Oct 26, 2020 Pfizer Hospital Business to acquire Arixa Pharma Written by Ruchika Sharma Published On 2020-10-26T11:00:54+05:30 | Updated On 26 Oct 2020 1:42 PM IST Palo Alto: …See details»
Pfizer to acquire antibiotic drug developer Arixa Pharmaceuticals
Oct 22, 2020 Pfizer Inc.'s hospital business is acquiring privately held antibiotic drug developer Arixa Pharmaceuticals Inc. for an undisclosed amount. Palo Alto, Calif.-based Arixa's lead …See details»
Arixa Pharmaceuticals - CB Insights
Explore {Arixa Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up
Oct 22, 2020 This summer, Pfizer teamed up with other Big Pharmas on a $1 billion fund to bolster struggling antibiotics makers. Now, the company is adding a new antibiotic candidate …See details»
Arixa Pharmaceuticals Announces Publication of Seminal Paper ...
Nov 12, 2018 Arixa Pharmaceuticals [email protected] or Media Burns McClellan, on behalf of Arixa Pharmaceuticals Nancie Steinberg / Robert Flamm, 212-213-0006 …See details»
Aisa Pharma, Inc. | Profervia® for Raynaud’s disease
Aisa Pharma is focused on developing a novel treatment for the pressing medical needs of patients with Systemic Sclerosis (or Scleroderma) who demonstrate Raynaud’s phenomenon.See details»